Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I just uploaded the webinar by Dr Linda Liau on DcVax. https://t.co/5gGSVpD9TV This version doesn't have the questions and answers section.. I am hoping to be able to upload that soon
— Al Musella (@AlMusella) December 11, 2022
He also said it wasn't related to nwbo
I read them.
If this was a movie those comments would be called foreshadowing. Cue the dramatic score and a closeup of Les.
Schwab sent a notice to me yesterday
Conger conjures up the image of a slippery eel in my mind.
Which means nwbo will be effectively treating a different kind of cancer.
Regardless of the merit of Stupp's arguments its a certainty the stock price will get shtupped. AF will have a field day with this.
Never forget that one option is to bankrupt a company then buy it.
Good thing we're trading on good news. I'd hate to see it if we got bad news.
Same at schwab. I saw this pattern at amrn after they lost their patent. The share price went to $4 and stayed there all day while record volume was being traded.
We open at 9:30
I nominate LL for the Nobel prize in medicine.
He's the ihub version of the Oracle of Delphi
My favorite line from that article
"Their dramatic results were dramatic"
Lol. Not even in clinical trials yet.
The preliminary proxy statement, also known as the PRE 14A, is a form required by the Securities and Exchange Commission (SEC) when there is a request of shareholder votes on items unrelated to an acquisition or a contested matter.
https://www.toppanmerrill.com › pr...
What is Preliminary Proxy Statement (PRE 14A)? - Toppan Merrill
File
Rule 14a-6(a) states that a preliminary proxy statement must be filed at least 10 calendar days prior to the filing of a definitive proxy statement. The day count starts on the day of filing. For example, if the company filed the preliminary proxy on April 1, then day 10 would be April 10.Feb 25, 2019
I don't forsee a gamestop scenario here for the simple reasons that gamestop is on the nyse and we're otc and gme has less than half the number of outstanding shares nwbo does. Many of the platforms the game apes trade on don't allow trading on the otc.
Your analogy between Crassus and big pharma is apt as his firefighters were a primary source of fires in Rome.
That's scary stuff. I was looking for it on Twitter but it was reported there that the book had been removed so thanks for that link.
$NWBO INTERESTING post- to say the least- on StockTwits- referenced a post on Investorhub: pic.twitter.com/IuKJHdZ2OU
— BioPharm_the_Magnificent (@crypto_biotech) December 3, 2022
I have stated here in the past that the only defense against shorts was an aggressive mgt response defending the stock and lamented that nwbo mgt were indifferent to the attacks. I take it all back.
A settlement will provide nwbo with operating capital, ensure the hedge funds are hands off nwbo because they know they're being watched, provide a blueprint for other companies to follow to defend themselves and provide their lawfirm with with a revenue source going forward as other companies follow nwbo's example. Going to trial involves a lot of time and resources best used elsewhere both on the part of nwbo and their lawfirm.
It's like a weight has been lifted. The weight of a thumb on the scales. Many thumbs in fact.
Large buys will take some time to accumulate the shares so a buyer may issue a buy order and not have it filled immediately.
Seems to me an algorithm could be designed to follow a company's stock and track spoofing. In fact, if there are any programmers here that would be a worthwhile project. One the SEC should be using.
Question per your comment on bullet #3. The comment was that he's not a medical doctor and has not participated in any clinical trials. I agree with you that he's received the appropriate training to be a medical doctor but has he practiced medicine and has he conducted any clinical trials in the medical field? If the answer to both of those is no then the statement is not factually incorrect.
A settlement can take a year or more if they drag it out.
Lawyers get paid either way. I endured the lawsuits at amrn and all the hyped comments regarding the quality of their legal team. In the end it all came down to a poor choice of venue by the legal team. It's a crap shoot when you go to court and I'm pretty sure the corporate lawyers at those hedge funds have done this before.
If there are as many naked shorts as has been speculated here the only hope for shorts is to bankrupt nwbo by taking the share price to zero. Personally I have my doubts about the speculated numbers.
For a fireman it seems like you start fires here rather than put them out. ;)
I think it's a fair question as to why nwbo has not received widespread media coverage after the JAMA publication, especially in the US as President Biden has a reason to be personally interested in the outcome.
I'm not at all optimistic about tomorrow or next week and expect a beating this week if there is no further news coming from mgt at the open tomorrow or during the week. Given mgts penchant for silence I have no confidence we'll see any such thing. I expect more "buying opportunities" are in the offing.
The stock markets close at 1 p.m. on early-closure days. Bond markets close early at 2 p.m. The list of stock market holidays has actually grown by one in 2022.
...
2022 Stock Market Holidays.
Date Friday, Dec. 30
Holiday New Year's Eve (Observed)
NYSE Open
Nasdaq Open
Bond Markets* Early close (2 p.m.)
JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
Journal Frequency and Access. JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives over 2.4 million online visits annually and more than 3.6 million article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.
Editorial Information. The journal’s acceptance rate is 13%. The median time to first decision is 2 days, and 43 days with review. The journal's Impact Factor is 33, one of the highest ranking among oncology journals.
It's clear to me who runs the show with regards to valuation here and it's AF and his cronies. Railing against them and calling for lawsuits is a waste of time. The only way to beat them is for management to vigorously defend the stock and we all know that doesn't happen here. I hope mgt has a sale of the company lined up and quickly. At this point I'll be happy with $5 a share so I can move on. Don't forget, the shorts can take a stock to zero and bankrupt a company and, according to Jim Cramer who used to do this for a living, that's the best outcome as shorts never have to buy back shares to cover.
It would be nice to see updated data from that trial if the participants are still being tracked. In any case, nwbo should be able to commence a stage 2 trial soon given the funding.
Phi slama JAMA for ancient basketball fans here.
No, it hasn't. That's an SNO article which is not peer reviewed.
Well if we're going to break 200 I'll probably sell at 199 and retire to the Bahamas